Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / Diseases and Disorders / Prostate Cancer / June 2005

Tip: Looking for answers? Try searching our database.

PSA Rollercoaster Ride

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
Pops - 16 Jun 2005 16:44 GMT
PSA 8/2003 = 1.24

PSA 10/2004 = 12.4

PSA 11/2004 = 15.7

LRP 1/24/2005. Cancer confirmed and confined, 2 tumors, Gleason 5, cure
prognosis excellent.

PSA 4/24/2005 = 0.24

scheduled EBRT to begin 5/31/2005.
scheduled another PSA for 5/25.

PSA came back as <0.1
Nobody knows why.
Postponed EBRT.
Scheduled another PSA for 6/14.

PSA came back as 0.12

Not sure what to do and am all ears (and PSA)!
Of course I'll talk to the urologist and oncologist.

I'm concerned about not taking immediate action mostly because of my
2003/2004 PSA readings. IMHO an order of magnitude jump indicates an
aggressive strain.

Anybody out there versed in PSA acceleration statistics and
indications?

Up and down, up and down. Hard to keep a good attitude.
ron - 16 Jun 2005 18:26 GMT
Hi Pops...My thoughts are to begin ultrasensitive testing, and hold
until a rising pattern appears, if one ever does.  Maybe you could
bounce that off your doc, if it makes sense to you.  It appears that
your most recent PSA tests are bouncing around 0.1.  An ultrasensitive
test will give you better visiblity to what's occurring in this region,
than the standard test.

Two things to keep in mind, 1) PSA varies quite a bit over the course
of a month, so some PSA variation is normal when PSA can be measured,
and 2) the study below suggests that about 9% of the men who recur
after surgery do not show PSA or clinical progression.  Hang in
there!..Best wishes and good health, Ron

Urology 2003 Feb;61(2):380-5

Biochemical recurrence without PSA progression characterizes a subset
of patients after radical prostatectomy. Prostate-specific antigen.

Shinghal R, Yemoto C, McNeal JE, Brooks JD Department of Urology,
Stanford University Medical Center, Stanford, California 94305-5118,
USA.

OBJECTIVES: To characterize a subset of patients with biochemical
recurrence after radical prostatectomy but with little, if any,
subsequent rise in serum prostate-specific antigen (PSA) and no
clinical progression during long-term follow-up.

METHODS: Of a series of 600 patients, 158 with biochemical recurrence
after radical prostatectomy were examined. We identified a subset with
measurable serum PSA levels during long-term follow-up, but with very
low PSA velocity and no clinical recurrence. Serum PSA was measured
with the ultrasensitive TOSOH assay with a PSA recurrence defined as a
serum PSA of 0.07 ng/mL or greater.

RESULTS: We identified 14 patients (8.8% of biochemical recurrences)
with a detectable serum PSA level after radical prostatectomy yet
without clinical or PSA progression at a mean follow-up after radical
prostatectomy of 10.3 years. The mean time to PSA recurrence was 5.8
years, and the mean PSA velocity after recurrence was 0.028 ng/mL/yr.
No clinical or pathologic features were found that could be used to
identify this subset of patients.

CONCLUSIONS: A subset of patients with biochemical recurrence after
radical prostatectomy will not exhibit a progressive rise in serum PSA
or clinical progression at 10 years follow-up. This suggests that serum
PSA kinetics should be observed after biochemical recurrence before
adjuvant hormonal therapy or radiotherapy.
Pops - 17 Jun 2005 13:17 GMT
Ron
Thanks for the info!

I guess it boils down, in my stupid head, to two questions.

1) Does measureable recurrent PSA mean there are cancer cells remaining
(e.g. I still have cancer) or is it just that prostate cells are
present and may or may not be cancerous?

2) Is my understanding correct that EBRT has a cure potential while
hormone thearpy simply slows down the growth?

My point is that if it is certain that I still  have cancer (no matter
how little) and if there is a cure potential, then I will not hesistate
to take that path unless the therapy invollved incurs higher risks than
watchful waiting.
ron - 21 Jun 2005 14:01 GMT
Hi Pops...I've been away for a few days, my answers are posted
below...Best wishes and good health, Ron

> Ron
> Thanks for the info!
[quoted text clipped - 4 lines]
> (e.g. I still have cancer) or is it just that prostate cells are
> present and may or may not be cancerous?

The latter is correct (prostate cells are present and may or may not be
cancerous).

> 2) Is my understanding correct that EBRT has a cure potential while
> hormone thearpy simply slows down the growth?

EBRT has a cure potential if the PCa is still localized in the prostate
area.  HT does kill prostate cancer cells.  There is some evidence
suggesting that if started early enough (e.g. before the immune system
is overwhelmed and before hormonal balance is lost) HT may be curative.
I have not seen any evidence that HT can be curative upon recurrence.

> My point is that if it is certain that I still  have cancer (no matter
> how little) and if there is a cure potential, then I will not hesistate
> to take that path unless the therapy invollved incurs higher risks than
> watchful waiting.

That makes sense to me.  Hope your next PSA comes in at 0.1 or lower,
Pops.  The waiting is the tough part...Good luck, Ron
Steve Kramer - 22 Jun 2005 01:10 GMT
> EBRT has a cure potential if the PCa is still localized in the prostate
> area.  HT does kill prostate cancer cells.  There is some evidence
> suggesting that if started early enough (e.g. before the immune system
> is overwhelmed and before hormonal balance is lost) HT may be curative.
>  I have not seen any evidence that HT can be curative upon recurrence.

Concur.  Not one of my readings has indicated that there is even a remote
chance that HT can be curative.  The only time I've heard the words uttered
were by my uro who basically said it's extremely rare, but possible for
those who have an extremely low amount of PCa in their system and/or only
those types of PCa cells that are responsive to HT.

He made it sound like it's a possibility, but not to make any decisions
based on the possibility.

Signature

PSA 16 10/17/2000 @ 46
Biopsy 11/01/2000 G7 (3+4), T2c
RRP 12/15/2000 G7 (3+4), T3cN0M0 Neg margins
PSA  .1  .1  .1  .27  .37  .75
EBRT 05-07/2002 @ 47
PSA  .34 .22 .15 .21 .32
Lupron 07/03 (1 mo) 8/03 (4 mo), 12/03, 4/04, 09/04, 01/05
PSA  .07 .05 .06 .05
non Illegitimi carborundum

Steve Kramer - 18 Jun 2005 03:00 GMT
Pops,

You're being put through a psychological stress test.  Cancer.  Cancer
cured.  Cancer not cure.  No sign of cancer.  Ever so slight rise in PSA.
Geesh!!

Were I you, I'd go back to the basics.  The definition of recurrent cancer
is three straight rises in PSA.  .24, .10 and .12 are all within acceptable
(although worrisome) standards and they do not represent three increases.

So, I would relax and wait for the next PSA or two.  You can certainly not
have any confidence in being cured.  However, you have to admit there is no
absolute indication that your cancer has recurred.

In the end, if your PSA goes up, EBRT is there and it represents a possible
cure.  If it doesn't go up, then no treatment is necessary.

Signature

PSA 16 10/17/2000 @ 46
Biopsy 11/01/2000 G7 (3+4), T2c
RRP 12/15/2000 G7 (3+4), T3cN0M0 Neg margins
PSA  .1  .1  .1  .27  .37  .75
EBRT 05-07/2002 @ 47
PSA  .34 .22 .15 .21 .32
Lupron 07/03 (1 mo) 8/03 (4 mo), 12/03, 4/04, 09/04, 01/05
PSA  .07 .05 .06 .05
non Illegitimi carborundum

> PSA 8/2003 = 1.24
>
[quoted text clipped - 28 lines]
>
> Up and down, up and down. Hard to keep a good attitude.
 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2008 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.